WHO approves Japan-made dengue vaccine
IndiaTimes
WHO approves TAK-003 (Qdenga) as 2nd dengue vaccine for children aged 6-16 in high-burden areas. Takeda in talks to launch in..
WHO approves TAK-003 (Qdenga) as 2nd dengue vaccine for children aged 6-16 in high-burden areas. Takeda in talks to launch in..
Global meningococcal vaccines market is segmented by type, and end-user. The market can be segmented based on type into conjugate..
Major players in the H1N1 vaccine market are Sanofi, Novartis AG, GlaxoSmithKline plc, CSL Limited, AstraZeneca, Zydus Cadila,..